Topic:Mycotic Rhinitis
Mycotic rhinitis in horses is an inflammatory condition of the nasal passages caused by fungal infection. It is characterized by the presence of fungal organisms within the nasal cavity, leading to symptoms such as nasal discharge, obstruction, and possible tissue damage. Common fungi associated with this condition include Aspergillus species. Diagnosis typically involves clinical examination, endoscopy, and microbial culture. Treatment may require antifungal medications and, in some cases, surgical intervention to remove fungal masses. This page gathers peer-reviewed research studies and scholarly articles that explore the etiology, pathophysiology, diagnostic approaches, and treatment options for mycotic rhinitis in equine patients.
Enilconazole treatment of horses with superficial Aspergillus spp. rhinitis. Mycotic rhinitis is an uncommon disease in horses with a wide range of clinical signs and treatment options based on case studies of a single or only a few individuals. Moreover, while dogs with mycotic rhinitis appear to respond well to treatment with topical enilconazole, this approach has yet to be reported in horses. Objective: The aim of this study was to describe the clinical findings, results of diagnostic investigations, treatment, and outcome in horses with mycotic rhinitis treated with topical enilconazole. Methods: Eight horses were included in the study. Methods: Medical records fr...
Treatment of mycotic rhinitis with itraconazole in three horses. Itraconazole, a third-generation azole, was evaluated for treatment of resistant nasal mycotic infections in horses. Two horses with Aspergillus spp nasal granulomas and 1 horse with Conidiobolus coronatus nasal infection were treated with itraconazole (3 mg/kg PO bid). One of the horses with nasal aspergillosis was also treated by surgical resection of the nasal septum. The treatment time for the horses ranged from 3 to 4.5 months. No adverse effects were noted in any of the horses during the treatment period. Peak and trough serum itraconazole concentrations were < 0.5 micrograms/mL in al...